Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5387 ARTÍCULOS , VIENDO DEL 976 AL 990

A Recurrent De Novo Variant in EIF2AK2 Causes a Hypomyelinating Leukodystrophy

Macintosh J, Thiffault I, Pastinen T, Sztriha L, Bernard G.

Child Neurol Open. 2023 May 29;10:2329048X231176673. doi: 10.1177/2329048X231176673. eCollection 2023 Jan-Dec.

Use of the EXOPULSE Mollii for severe ataxia in an adult male 4 months after cardiac arrest

Wagner V, Knudsen MS, Curtis DJ, Riberholt CG.

BMJ Case Rep. 2023 Mar 24;16(3):e249574. doi: 10.1136/bcr-2022-249574.

Clinical and imaging "red flags" for the diagnosis of multiple system atrophy lookalikes

Gallo S, Ory-Magne F, Le-Traon AP, Rascol O, Debs R, Leung C, Fabbri M.

Parkinsonism Relat Disord. 2023 Jul;112:105372. doi: 10.1016/j.parkreldis.2023.105372. Epub 2023 Mar 20.

Expanding the spectrum of KIF5A mutations-case report of a large kindred with familial ALS and overlapping syndrome

Dulski J, Strongosky AJ, Al-Shaikh RH, Wszolek ZK.

Amyotroph Lateral Scler Frontotemporal Degener. 2023 May;24(3-4):347-350. doi: 10.1080/21678421.2022.2164204. Epub 2023 Jan 5.

Adult-Onset White Matter Vanishing Disease With Ovarian Failure in a Salvadoran Patient

Flores Lazo SL, Salazar-Orellana JLI.

Cureus. 2023 Jun 3;15(6):e39900. doi: 10.7759/cureus.39900. eCollection 2023 Jun.

Spastic paraplegia is the main manifestation of a spinocerebellar ataxia type 8 lineage in China: a case report and review of literature

Chen S, Li S, Liu Y, She R, Jiang W.

Front Hum Neurosci. 2023 Jul 17;17:1198309. doi: 10.3389/fnhum.2023.1198309. eCollection 2023.

Progressive degeneration in a new Drosophila model of Spinocerebellar Ataxia type 7

Sujkowski AL, Ranxhi B, Prifti MV, Alam N, Todi SV, Tsou WL.

bioRxiv [Preprint]. 2023 Nov 11:2023.11.07.566106. doi: 10.1101/2023.11.07.566106.

Progressive degeneration in a new Drosophila model of Spinocerebellar Ataxia type 7

Sujkowski AL, Ranxhi B, Prifti MV, Alam N, Todi SV, Tsou WL.

Res Sq [Preprint]. 2023 Nov 23:rs.3.rs-3592641. doi: 10.21203/rs.3.rs-3592641/v1.

Clinical Reasoning: A 48-Year-Old Man With Spasticity and Progressive Ataxia

Vizcarra JA, Paul RA, Hamedani AG, Lynch DR, Aamodt WW.

Neurology. 2023 Oct 24;101(17):e1747-e1752. doi: 10.1212/WNL.0000000000207658. Epub 2023 Aug 18.

Spastic paraplegia type 76 due to novel CAPN1 mutations: three case reports with literature review

Zhu Z, Hou W, Cao Y, Zheng H, Tian W, Cao L.

Neurogenetics. 2023 Oct;24(4):243-250. doi: 10.1007/s10048-023-00726-8. Epub 2023 Jul 19.

Frontal lobe motor syndromes

Thompson AE, Thompson PD.

Handb Clin Neurol. 2023;196:443-455. doi: 10.1016/B978-0-323-98817-9.00008-9.

Gait analysis patterns and rehabilitative interventions to improve gait in persons with hereditary spastic paraplegia: a systematic review and meta-analysis

Faccioli S, Cavalagli A, Falocci N, Mangano G, Sanfilippo I, Sassi S.

Front Neurol. 2023 Sep 20;14:1256392. doi: 10.3389/fneur.2023.1256392. eCollection 2023.

Immunogenicity to Botulinum Toxin Type A: A Systematic Review With Meta-Analysis Across Therapeutic Indications

Rahman E, Alhitmi HK, Mosahebi A.

Aesthet Surg J. 2022 Jan 1;42(1):106-120. doi: 10.1093/asj/sjab058.

The Efficacy, Adverse Events, and Withdrawal Rates of the Pharmacological Management of Chronic Spinal Cord Injury Pain: A Systematic Review and Meta-Analysis

Canavan C, Inoue T, McMahon S, Doody C, Blake C, Fullen BM.

Pain Med. 2022 Feb 1;23(2):375-395. doi: 10.1093/pm/pnab140.

GABA(B) Receptor Chemistry and Pharmacology: Agonists, Antagonists, and Allosteric Modulators

Nieto A, Bailey T, Kaczanowska K, McDonald P.

Curr Top Behav Neurosci. 2022;52:81-118. doi: 10.1007/7854_2021_232.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias